SCHEMBL5585827

SCHEMBL5585827

COc1ccc(Br)cc1NC(=O)Nc1cccc2c1ccn2Cc1cccnc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.49
EGFR P00533 1/20 0.47
ERBB4 Q15303 1/20 0.47
GAA P10253 2/20 0.46
ALDH1A1 P00352 2/20 0.46
KDR P35968 2/20 0.45
EPHB4 P54760 1/20 0.45
TEK Q02763 1/20 0.45
IRAK4 Q9NWZ3 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
AHR P35869 1/20 0.43
MAPT P10636 3/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
USP2 O75604 1/20 0.42
HTT P42858 1/20 0.42
KDM4E B2RXH2 1/20 0.42
PKM P14618 1/20 0.42
ATM Q13315 1/20 0.41
PTK2 Q05397 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5585843 0.90 EPHB4 (0.52) ERBB4GAAALDH1A1KDREPHB4
SCHEMBL5959769 0.85 EPHB4 (0.45) POLBGAAKDREPHB4TEK
SCHEMBL5599451 0.85 KDR (0.43) GAAALDH1A1KDREPHB4TEK
SCHEMBL5600156 0.85 EPHB4 (0.46) ERBB4GAAALDH1A1KDREPHB4
SCHEMBL5592785 0.85 EPHB4 (0.46) GAAALDH1A1KDREPHB4TEK
SCHEMBL5601036 0.85 EPHB4 (0.46) GAAALDH1A1KDREPHB4TEK
SCHEMBL5586048 0.84 ERBB4 (0.58) POLBEGFRERBB4GAAALDH1A1
Ji-101 SCHEMBL5585996 0.84 EPHB4 (0.46) GAAALDH1A1KDREPHB4TEK
Ji-101 SCHEMBL29375077 0.84 EPHB4 (0.46) GAAALDH1A1KDREPHB4TEK
SCHEMBL5592763 0.84 EPHB4 (0.46) GAAALDH1A1KDREPHB4TEK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110416553-B Proton membrane fuel cell catalyst, preparation method thereof and fuel cell system 奇瑞商用车(安徽)有限公司 2023-12-01 CN claimed
EP-1858879-B1 1,3-DIARYL SUBSTITUTED UREAS AS MODULATORS OF KINASE ACTIVITY GILEAD CONNECTICUT INC (US) 2012-06-06 EP claimed
US-20060199846-A1 Certain substituted ureas as modulators of kinase activity GILEAD CONNECTICUT, INC. 2006-09-07 US claimed
CN-118235272-A Membrane-electrode assembly for fuel cell comprising linear porous silica nanoparticles, and fuel cell comprising the same 可隆工业株式会社 2024-06-21 CN disclosed
CN-115039262-B Polymer electrolyte membrane and membrane-electrode assembly including the same 可隆工业株式会社 2024-06-18 CN disclosed
CN-118176608-A Membrane electrode assembly of fuel cell including plate-shaped porous silicon and fuel cell including the same 可隆工业株式会社 2024-06-11 CN disclosed
CN-118160120-A Reinforced composite membrane for fuel cell, method of manufacturing the same, and membrane electrode assembly including the same 可隆工业株式会社 2024-06-07 CN disclosed
EP-3451428-B1 FUEL CELL MEMBRANE-ELECTRODE ASSEMBLY KOLON INC (KR) 2023-08-02 EP disclosed
CN-111418104-B Polymer electrolyte membrane, method of preparing the same, and membrane electrode assembly including the same 可隆工业株式会社 2023-05-16 CN disclosed
US-20230006232-A1 METHOD FOR MANUFACTURING POLYMER ELECTROLYTE MEMBRANE, AND ELECTROLYTE MEMBRANE MANUFACTURED BY SAME KOLON INDUSTRIES, INC. (KR) 2023-01-05 US disclosed
US-20220416284-A1 POLYMER ELECTROLYTE MEMBRANE AND MEMBRANE ELECTRODE ASSEMBLY COMPRISING SAME KOLON INDUSTRIES, INC. (KR) 2022-12-29 US disclosed
US-20140186742-A1 CATALYST FOR FUEL CELL, AND ELECTRODE FOR FUEL CELL, MEMBRANE-ELECTRODE ASSEMBLY FOR FUEL CELL, AND FUEL CELL SYSTEM INCLUDING SAME HYUNDAI MOTOR COMPANY (KR) 2014-07-03 US disclosed
US-20120141913-A1 POLYMER ELECTROLYTE MEMBRANE FOR POLYMER ELECTROLYTE FUEL CELL, METHOD OF MANUFACTURING THE SAME AND POLYMER ELECTROLYTE FUEL CELL SYSTEM INCLUDING THE SAME IUCF-HYU (Industry-University Cooperation Foundati on Hanyang University (KR) 2012-06-07 US disclosed
EP-1858879-B1 1,3-DIARYL SUBSTITUTED UREAS AS MODULATORS OF KINASE ACTIVITY GILEAD CONNECTICUT INC (US) 2012-06-06 EP disclosed
EP-1858879-B1 1,3-DIARYL SUBSTITUTED UREAS AS MODULATORS OF KINASE ACTIVITY GILEAD CONNECTICUT INC (US) 2012-06-06 EP disclosed
EP-2397478-A1 1,3-diaryl substituted ureas as modulators of kinase activity. CGI Pharmaceuticals, Inc. (US) 2011-12-21 EP disclosed
EP-2397478-A1 1,3-diaryl substituted ureas as modulators of kinase activity. CGI Pharmaceuticals, Inc. (US) 2011-12-21 EP disclosed
EP-1858879-A1 1,3-DIARYL SUBSTITUTED UREAS AS MODULATORS OF KINASE ACTIVITY CGI Pharmaceuticals, Inc. (US) 2007-11-28 EP disclosed
US-20060199846-A1 Certain substituted ureas as modulators of kinase activity GILEAD CONNECTICUT, INC. 2006-09-07 US disclosed
WO-2006076593-A1 1,3-DIARYL SUBSTITUTED UREAS AS MODULATORS OF KINASE ACTIVITY CGI PHARMACEUTICALS, INC. (US) 2006-07-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060199846-A1 Certain substituted ureas as modulators of kinase activity UCK2, CHUK, AXL POLB 3113/4885EGFR 98/4885ERBB4 85/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.